Raghavan Lab

Targeting Cellular Plasticity in Gastrointestinal Cancers

The Raghavan Lab at Dana-Farber Cancer Institute is a basic and translational oncology lab focused on understanding mechanisms of cell-state regulation in cancer, evaluating how cell-state plasticity influences therapeutic response and tumor evolution, and applying these insights toward the discovery of new therapeutic approaches for patients with pancreatic and biliary cancers.

We actively collaborate with clinical, laboratory, and computational colleagues within the Hale Family Center for Pancreatic Cancer Research and more broadly at Dana-Farber Cancer Institute, MIT, and the Broad Institute on basic and translational research projects, with the shared goal of improving outcomes for patients with gastrointestinal cancers.